Visikol’s Unique Blood Brain Barrier Assay
The brain is the central control system of our bodies, which is why it is so heavily protected by [...]
In Vitro Models: An Alternative to In Vivo Studies
Drug development is a complex and expensive process that requires extensive testing to ensure safety and efficacy. Traditionally, in [...]
Human Liver Diseases and Hepatocyte In Vitro Cell Culture Model
The human liver is a remarkable organ with vital functions that impact metabolism, detoxification, and protein synthesis. Understanding liver [...]
Challenging Cell Lines for Successful Spheroid Formation
Are you struggling to achieve the optimal 3D cell culture model? You are not alone in this, as many [...]
Visikol’s Continued Development of Blood Brain Barrier Model
Each morning the first thing a person does is think about their day. It may start with making coffee [...]
Visikol’s Commitment to Reducing Animals in Research
Like many of the BICO companies, Visikol is highly focused on reducing the usage of animals in research and [...]
Visikol to Present at the 5th Annual Drug Discovery & Development Conference
Labroots Drug Discovery & Development 2022 Labroots and the Drug Discovery planning committee are pleased [...]
2D vs 3D In Vitro Models for Use in Drug Discovery
Figure 1: Differential proliferative response in 2D vs. 3D cell culture The drug discovery and development process is [...]
Visikol to present at SELECTBIO’s December 2021 Conference
Visikol's Director of Drug Discovery, Peter Worthington Ph.D., to Present at SELECTBIO's 3D-Cell Culture, Organoids, and Organs-on-Chips Conference [...]
Increasingly Positive Cancer Outcomes Puts Cardiac Side Effects Center Stage
The five-year relative survival for all cancer sites has been steadily improving since the 1980s. Because cancer is becoming [...]